xFOREST Therapeutics is a drug discovery platform provider, founded in Kyoto, Japan in May 2020, specializing in small molecule drug discovery targeting RNA. Leveraging its proprietary "FOREST technologies," the company enables the identification of small molecules that selectively bind to RNA and exhibit biological activity. This innovative approach opens new avenues for addressing disease areas driven by RNA targets that have been difficult to approach using conventional methods. Building on this advanced technological foundation, xFOREST Therapeutics offers comprehensive support across various stages of early drug discovery—from RNA structure-based molecule screening to evaluation and optimization. As a pioneering partner in RNA-targeted drug discovery, xFOREST Therapeutics is committed to advancing the field and unlocking new therapeutic possibilities.